Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Nature Publishing Group full text link Nature Publishing Group Free PMC article
Full text links

Actions

Share

.2013 Sep;19(9):1166-72.
doi: 10.1038/nm.3258. Epub 2013 Aug 11.

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

Affiliations

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

Clinton S Robbins et al. Nat Med.2013 Sep.

Abstract

During the inflammatory response that drives atherogenesis, macrophages accumulate progressively in the expanding arterial wall. The observation that circulating monocytes give rise to lesional macrophages has reinforced the concept that monocyte infiltration dictates macrophage buildup. Recent work has indicated, however, that macrophage accumulation does not depend on monocyte recruitment in some inflammatory contexts. We therefore revisited the mechanism underlying macrophage accumulation in atherosclerosis. In murine atherosclerotic lesions, we found that macrophages turn over rapidly, after 4 weeks. Replenishment of macrophages in these experimental atheromata depends predominantly on local macrophage proliferation rather than monocyte influx. The microenvironment orchestrates macrophage proliferation through the involvement of scavenger receptor A (SR-A). Our study reveals macrophage proliferation as a key event in atherosclerosis and identifies macrophage self-renewal as a therapeutic target for cardiovascular disease.

PubMed Disclaimer

Conflict of interest statement

Author information

The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to F.K.S. (fswirski@mgh.harvard.edu), Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Simches Research Building, 185 Cambridge St., Boston, MA 02114; phone, 617-724-6242, fax, 617-643-6133 or C.S.R. (clint.robbins@utoronto.ca), Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network, Toronto Medical Discovery Tower, 101 College St., Toronto, ON M5G1L7; phone, 416-581-7510.

Figures

Figure 1
Figure 1. Macrophages turn over rapidly in lesions
(a) Identification of aortic macrophages in established atherosclerosis. Contour plots demonstrate gating scheme for aortic macrophages inApoe−/− mice consuming HCD for 8 weeks. (b) BrdU-containing osmotic pumps were implanted inApoe−/− mice consuming HCD for 8 weeks. Data depict BrdU incorporation in aortic macrophages 1 and 4 weeks following implantation of osmotic pumps. (c) Percentage of aortic macrophages that incorporate BrdU. Shown is quantification of data in b as well as BrdU+ macrophages in mice where pumps were removed for 4 weeks (mean ± SEM, n = 8 (week 1), n = 3 (week 4), n = 2 (week 4 removal)). (d) Immunofluorescence (IF) shows BrdU+ Mac3+ macrophages in aortic root lesions. (e) IF showing co-localization of BrdU and DAPI in intimal and adventitial macrophages of aortic root sections following 4 weeks of BrdU administration; 10x magnification. (f) Enumeration of BrdU+ Mac3+ macrophages by IF in aortic root sections (mean ± SEM, n = 2–3). *P < 0.05. (g) Lesion growth during BrdU labeling period. (h) Lesional macrophage content during BrdU labeling period. Data show area staining for Mac-3.
Figure 2
Figure 2. Lesional macrophage accumulation occurs largely independent of monocyte recruitment
(a) Effect of repeated clodronate liposome administration on peripheral blood monocytes (mean ± SEM, n = 4). (b) Effect of clodronate liposome treatment on BrdU incorporation by aortic macrophages. Data show percentage of BrdU+ macrophages in aortic tissue following 5 d clodronate administration (mean ± SEM, n = 6–9). (c) Data show number of BrdU+ macrophages in aortic tissue following 5 d clodronate treatment (mean ± SEM, n = 6–9). (d) Data show total number of macrophages in aortic tissue following 5 d clodronate treatment (mean ± SEM, n = 6–9). (e) CD45.1+ and CD45.2+Apoe−/− HCD mice were joined in parabiosis for 5 weeks. Data show Ly-6Chigh monocyte chimerism in the blood, spleen, and aorta and macrophage chimerism in the aortic tissue (mean ± SEM; n = 6–8). (f) Representative contour plots demonstrate monocyte and macrophage chimerism in aortic tissue. (g) Immunohistochemistry (IHC) of aortic root sections showing CD45.1 and CD45.2 staining in CD45.1+ parabionts. (h) CD45.1+ and CD45.2+Apoe−/− HCD mice were joined in parabiosis for 5 weeks, separated and assessed for chimerism 2 weeks later. Shown is chimerism for monocytes in the blood, spleen, and aorta as well as macrophages in the aorta (mean ± SEM; n = 4–8).*P < 0.05.
Figure 3
Figure 3. In situ proliferation dominates macrophage accumulation in atherosclerosis
(a) Data show colony-forming units–granulocytes and macrophages (CFU-GM) in spleen, bone marrow and aortic tissue ofApoe−/− HCD mice (mean ± SEM, n = 3). *P < 0.05. (b) BrdU incorporation following adoptive transfer of GFP+ Ly6Chigh monocytes. One representative experiment is shown. (c) BrdU pulse labeling of aortic macrophages (mean ± SEM, n = 7). (d) Cell cycle analysis of aortic tissue macrophages. Histograms depict DAPI staining (mean ± SEM, n = 7). *P < 0.05. (e) Percentage of aortic tissue macrophages in S and G2/M phases of the cell cycle. (mean ± SEM, n = 3–7). *P < 0.05. (f) Phospho-histone H3 staining of aortic macrophages in G2/M phases of the cell cycle. (g) Analysis of aortic macrophages by ImageStreamX™ imaging flow cytometry platform. Data depict actively dividing macrophages. (h) IF of aortic root sections demonstrating Ki-67 staining of Mac3+ intimal macrophages. (i) CD45.1+ and CD45.2+Apoe−/− HCD mice were joined in parabiosis and then implanted with BrdU containing osmotic pumps. Data show chimerism in newly made (BrdU+) aortic tissue macrophages. One representative experiment of two is shown. Monocyte chimerism in peripheral blood is also shown. (j) Relative contribution of in situ proliferation and monocyte recruitment to macrophage accumulation in early (2–3 month old) and established (4–5 months old) atherosclerosis.
Figure 4
Figure 4. Lesion microenvironment dictates macrophage proliferation
(a) WT (CD45.1+ C57BL6/J) and CD45.2+Apoe−/− HCD mice were joined in parabiosis for 5 weeks. Data show DAPI staining in CD45.1+ and CD45.2+ aortic tissue macrophages in each parabiont. One representative experiment of 3 is shown. (b) Enumeration of data in a. (mean ± SEM, n = 8–9). * P < 0.05. (c) Cell cycle analysis of intimal versus adventitial aortic macrophages. (d) WT/Msr1−/−mixed chimeras were generated by reconstituting lethally irradiatedLdlr−/− mice with CD45.1+ wild type (Msr1+/+) and CD45.2+Msr1–deficient (Msr1−/−) bone marrow cells. (e) Data show number of BrdU+Msr1+/+ (WT) and BrdU+Msr1−/−Ly6Chigh monocytes in blood 2 h following BrdU pulse labeling. (mean ± SEM, n = 5). (f) Percentage of WT andMsr1−/− aortic macrophages that are BrdU+. (mean ± SEM, n = 5).* P < 0.05. (g) Number of BrdU+Msr1+/+and BrdU+Msr1−/− macrophages in aortic tissue of WT/Msr1−/− mixed chimeras. (mean ± SEM, n = 5).*P < 0.05. (h) Cartoon depicting macrophage expansion in established atherosclerosis.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339:161–166. - PMC - PubMed
    1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519. - PubMed
    1. Kim CJ, et al. Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tumor necrosis factor-alpha and interleukin-1 beta. Arterioscler Thromb Vasc Biol. 2000;20:1976–1982. - PubMed
    1. Lessner SM, Prado HL, Waller EK, Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol. 2002;160:2145–2155. - PMC - PubMed
    1. Swirski FK, et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A. 2006;103:10340–10345. - PMC - PubMed

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full text links
Nature Publishing Group full text link Nature Publishing Group Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp